Close Menu
Home › Biocartis, Nichirei Bioscience Ink Commercialization Agreement for Japan

Biocartis, Nichirei Bioscience Ink Commercialization Agreement for Japan

Jan 07, 2019

NEW YORK (GenomeWeb) – Biocartis announced today it has signed a commercialization agreement with Nichirei Bioscience, a supplier of biological and diagnostics products in Japan.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

What's Popular?

In PCR

  1. Biocartis, AstraZeneca Expand Lung Cancer Biomarker Study With Master Collaboration Agreement

  2. OraSure's DNA Genotek Gets FDA Clearance for Sample Collection Kits

  3. Heart Transplant Monitoring Test From TAI Diagnostics Validated in New Study

    Premium

  4. Myriad Genetics Files for FDA Approval of BRACAnalysis CDx for Lynparza in Prostate Cancer

  5. Ontera Developing Single-Pore Sensor for Sepsis, TB, and Zika Diagnostic Testing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.